109694 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses Demonstrated effect
MODIFIED ADENOVIRUSES
#2IMMUNOMODULATORY FUSION PROTEINS
#3ADENOVIRAL VECTOR SYSTEM FOR GENE DELIVERY
#4ONCOLYTIC ADENOVIRUSES FOR TREATING CANCER
#5VECTOR FOR CANCER TREATMENT
#6COMPOSITIONS, KITS AND METHODS FOR TREATMENT OF COMPLEMENT-RELATED DISORDERS
#7IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#8VIRUS
#9IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#10METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#11USE OF ONCOLYTIC ADENOVIRUS FOR THE TREATMENT OF PEDIATRIC BRAIN CANCER
#12Covalently-modified steroid acid-peptides having enhanced stability and/or biological activity
#13Immunogenic compositions and uses thereof
#14GORILLA ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF
#15Modified adenoviruses
#16METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#17MESENCHYMAL STEM CELLS THAT ENABLE TUMOR TARGETING IMPROVEMENT AND VIRUS MASS-PRODUCTION
#18VECTOR FOR CANCER TREATMENT
#19Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#20VISMODEGIB IN COMBINATION WITH A REPLICATION-DEFICIENT TYPE 5 ADENOVIRUS FOR EXPRESSION OF INTERFERON GAMMA FOR THE TREATMENT OF SKIN CANCER
#21Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#22ADENOVIRAL- BASED BIOLOGICAL DELIVERY AND EXPRESSION SYSTEM FOR USE IN THE TREATMENT OF OSTEOARTHRITIS
#23Adenoviral vector system for gene delivery
#24AD36E4ORF1: A THERAPEUTIC TREATMENT FOR ALZHEIMER'S DISEASE
#25Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#26AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 IN LIQUID FORM (VARIANTS)
#27PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2
#28Modified adenoviruses
#29ADENOVIRAL-BASED BIOLOGICAL DELIVERY AND EXPRESSION SYSTEM FOR USE IN THE TREATMENT OF OSTEOARTHRITIS
#30Compositition and uses of teleost invariant chain to enhance T cell response to a vaccine
#31Adenovirus and uses thereof
#32Immunomodulatory fusion proteins
#33NOVEL APPLICATION OF HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR FOR MEDICAL PURPOSES
#34MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) COMPOSITIONS AND METHODS OF USE THEREOF
#35ONCOLYTIC ADENOVIRUS COMPOSITIONS WITH ENHANCED REPLICATION PROPERTIES
#36MODIFIED ONCOLYTIC ADENOVIRUSES
#37TROPISM MODIFIED CANCER TERMINATOR VIRUS (AD.5/3 CTV;AD.5/3-CTV-M7)
#38Immunogenic compositions and uses thereof
#39Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#40COMPOSITIONS, KITS AND METHODS FOR TREATMENT OF COMPLEMENT-RELATED DISORDERS
#41Adenovirus comprising an albumin-binding moiety
#42Therapeutic compositions and methods of use for treating cancer
#43Adenovirus polynucleotides and polypeptides
#44Oncolytic virus and method
#45ADENOVIRAL-BASED BIOLOGICAL DELIVERY AND EXPRESSION SYSTEM FOR USE IN THE TREATMENT OF OSTEOARTHRITIS
#46Virus
#47Oncolytic adenoviruses for treating cancer
#48Immunogenic compositions and uses thereof
#49Tropism modified cancer terminator virus (Ad.5/3 CTV;Ad.5/3-CTV-M7)
#50Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Production and Use Thereof for Treatment of Cancer
#51Oncolytic adenovirus encoding a B7 protein or active fragment
#52COMBINING ADENOVIRUS AND CHEMOTHERAPEUTIC AGENTS FOR TREATING CANCER
#53Vectors for expression of prostate-associated antigens
#54Immunogenic compositions and uses thereof
#55Composition for diagnosing, preventing, or treating vascular smooth muscle cell proliferative diseases using FGF12
#56Methods and compositions for combination immunotherapy
#57Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
#58Human type 55 replication defective adenovirus vector, method for preparing same and uses thereof
#59Adenovirus polynucleotides and polypeptides
#60Oncolytic adenovirus encoding a B7 protein
#61Immunomodulatory fusion proteins
#62THERAPEUTIC COMPOSITIONS AND METHODS OF USE FOR TREATING CANCER
#63Canine adenovirus vectors
#64METHODS AND COMPOSITIONS FOR ENHANCING CARDIAC CONTRACTILITY FOR TREATMENT OF HEART FAILURE
#65Oncolytic adenovirus encoding a B7 protein
#66Oncolytic adenovirus encoding a therapeutic protein or active fragment
#67Method and compositions
#68HPV vaccines and methods of use thereof
#69Adenoviral vector vaccine
#70Breast cancer vaccines and methods of use thereof
#71Oncolytic adenovirus encoding a B7 protein or active fragment
#72Adenovirus comprising an albumin-binding moiety
#73Immunogenic compositions and uses thereof
#74Vectors for expression of prostate-associated antigens
#75Dry formulations of vaccines that are room temperature stable
#76Method to kill pathogenic microbes in a patient
#77Treatment and prevention of malaria
#78Tropism modified cancer terminator virus (Ad.5/3 CTV;AD.5/3-CTV-M7)
#79Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)
#80Endothelial cell-specific polynucleotides and use thereof
#81Adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis
#82LPL variant therapeutics
#83Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof
#84Sequential administration of a replication defective adenovirus vector in vaccination protocols
#85Heterologous prime boost vaccination regimen against malaria
#86Compositions, kits and methods for treatment of complement-related disorders
#87Therapeutic Use of Growth Factor, and Delivery Device, Especially for the Treatment of Intimal Hyperplasia
#88Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein
#89MICROBUBBLE ASSISTED VIRAL DELIVERY
#90Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses
#91Oncolytic adenoviruses for treating cancer
#92NON-AD5 ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#93POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA
#94GENE THERAPY VECTOR FOR TREATMENT OF STEROID GLAUCOMA
#95Porcine Adenovirus 3-Based PRRSV Vaccines
#96Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof
#97POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA
#98COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#99Sequential administration of a replication defective adenovirus vector in vaccination protocols
#100Adenoviral vectors and methods and uses related thereto
#101Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof
#102Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors
#103ADENOVIRUS VACCINE UTILIZING IKK AS ADJUVANT
#104Application of heparin-binding epidermal growth factor-like growth factor for medical purposes
#105Compositions and methods for the therapy and diagnosis of lung cancer
#106Therapy for primary and metastatic cancers
#107Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
#108Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity
#109Compositions and methods for the therapy and diagnosis of lung cancer
#110Mechanisms of myoblast transfer in treating heart failure
#111Method of reducing side effects of cancer therapy using p53 recombinant adenovirus
#112Methods for the detection of cervical cancer